10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Biomarin Pharmaceutical, Inc. (BMRN) CEO Jean Jacques Bienaime sells 8,000 Shares

November 19, 2012 | About:
insider

insider

57 followers
CEO of Biomarin Pharmaceutical, Inc. (BMRN) Jean Jacques Bienaime sells 8,000 shares of BMRN on 11/16/2012 at an average price of $48.05 a share.

Biomarin Pharmaceutical, Inc. has a market cap of $5.92 billion; its shares were traded at around $47.89 with and P/S ratio of 13.4.

This is the annual revenues and earnings per share of BMRN over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of BMRN.


CEO Recent Trades:



  • CEO Jean Jacques Bienaime sold 8,000 shares of BMRN stock on 11/16/2012 at the average price of 48.05. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 0.33% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 11/14/2012 at the average price of 48.5. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has decreased by 1.26% since.
  • CEO Jean Jacques Bienaime sold 7,000 shares of BMRN stock on 11/09/2012 at the average price of 47.62. Jean Jacques Bienaime owns at least 167,691 shares after this. The price of the stock has increased by 0.57% since.
  • CEO Jean Jacques Bienaime sold 4,000 shares of BMRN stock on 10/31/2012 at the average price of 37.96. Jean Jacques Bienaime owns at least 174,691 shares after this. The price of the stock has increased by 26.16% since.
  • CEO Jean Jacques Bienaime sold 3,000 shares of BMRN stock on 10/22/2012 at the average price of 41.86. Jean Jacques Bienaime owns at least 175,691 shares after this. The price of the stock has increased by 14.41% since.

This is the insider trade history vs. stock price of BMRN. For the complete insider trading history of BMRN, click here.




Directors and Officers Recent Trades:



  • EVP, Technical Operations Robert Baffi sold 20,000 shares of BMRN stock on 11/15/2012 at the average price of 51. Robert Baffi owns at least 100,413 shares after this. The price of the stock has decreased by 6.1% since.
  • VP, Corporate Controller Brian Mueller sold 15,812 shares of BMRN stock on 11/15/2012 at the average price of 50. Brian Mueller owns at least 15,340 shares after this. The price of the stock has decreased by 4.22% since.
  • SVP, General Counsel George Eric Davis sold 99,075 shares of BMRN stock on 11/12/2012 at the average price of 48.45. George Eric Davis owns at least 51,322 shares after this. The price of the stock has decreased by 1.16% since.
  • SVP, Chief Commercial Of Jeffrey Robert Ajer sold 265 shares of BMRN stock on 11/12/2012 at the average price of 48.11. Jeffrey Robert Ajer owns at least 10,570 shares after this. The price of the stock has decreased by 0.46% since.
  • Director Elaine J Heron sold 1,875 shares of BMRN stock on 11/12/2012 at the average price of 48.33. Elaine J Heron owns at least 14,025 shares after this. The price of the stock has decreased by 0.91% since.


For the complete insider trading history of BMRN, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK